Docs prefer e-detailing slightly less in 2009

The number of physicians who like e-detailing dipped nearly 10% from 2008 to 2009, according to a recent study.

Fifty-eight percent reported feeling positively or very positively about e-marketing, down from 67% in 2008. Results are based on answers from about 1,200 tech-savvy doctors in 15 specialties. “The majority were still positive, but a greater percentage were either neutral or negative,” said Melissa Leonhauser, director of strategic marketing for SDI, which fields the ePromotion attitudinal study every October. SDI defines ePromotion as video details, online events and virtual details.

On the positive side, more said that ePromotion was inferior to the face-to-face kind (34% in 2009 vs. 27% in 2008), although the majority continued to regard the two equally well and slightly more were replacing face-to-face with online. Also, compared to 2008, physicians said they were more likely to take action after participating in ePromotion, including request samples, watch a video or podcast or conduct research.

You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.